Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine Plus 3-weekly Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00401427Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2002
- Primary completion
- Jun 2006
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by National Cancer Institute. Started Nov 2002; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00401427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00401427.